| INTRODUCTION
We present the case of a patient suffering from a composite lymphoma combining a Hodgkin lymphoma and a diffuse large B-cell lymphoma (DLBCL) revealed by a hemophagocytic syndrome. Bone marrow analysis revealed a surprising discrepancy between the results of the bone marrow aspirate which suggested the diagnosis of DLBCL and that of the bone marrow biopsy, in favour of a marginal zone lymphoma associated with a classic Hodgkin lymphoma (HL). The patient was treated for the Hodgkin lymphoma component of his malignancy. After two cycles of ABVD, a CD10+ lymphocyte population remained, compatible with a DLBCL. The final diagnosis was a Richter syndrome with transformation of a marginal zone lymphoma into a DLBCL, associated with a Hodgkin lymphoma.
| CASE REPORT
A 70-year-old man was addressed to the emergency department with a suspicion of prostatitis. His medical history included urethral stricture requiring self-urinary catheterization, and kidney failure. Anamnesis and clinical examination revealed an alteration of general state (asthenia, anorexia and status 2 of WHO performance) associated with fever at 39.6°C and sweats that had lasted for 2 weeks. Two different antibiotic treatments (Sulfamethoxazol-Trimethoprim first, then Amoxicillin) were given, without any improvement. The initial blood count showed a anaemia (haemoglobin at 12.1 g/dL), neutrophilia (neutrophils at 16.8 × 10 9 /L), and | CLAIRE Et AL.
( Figure 1C,D) . Cytobacteriological examination of urine was negative. An abdominal computerized tomography (CT) scan revealed a hepato-splenomegaly associated with coeliac and mesenteric adenopathy. The patient was admitted to the hospital in order to explore a probable hematologic malignancy.
A biochemistry panel showed highly increased levels of blood ferritin levels at 51 681 pmol/L, associated with hypertriglyceridemia at 3 mmol/L and discrete cytolysis, leading to a strong suspicion of hemophagocytic syndrome, with a Fardet 1 probability score of 88.2%. A marrow aspiration was carried out. There was a major infiltration of bone marrow with macrophages but no clear diagnosis of hemophagocytosis could be performed. Nearly, half of the lymphocytes observed had morphology compatible with a DLBCL including large lymphocytes, with a basophilic cytoplasm; a regular nucleus and a compacted chromatin including a nucleolus ( Figure 2A ). Cytological analysis revealed also the presence of large atypical cells with intense basophilic cytoplasm containing vacuoles, with irregular nuclei, and some binucleated cells with decondensed chromatin and multiple nucleoli ( Figure 2B ). These cells were thought to be Reed-Sternberglike cells which may be observed in patients with DLBCL. [2] [3] [4] Immunophenotypic analysis performed on the bone marrow aspirate demonstrated the presence of a heterogeneous B population monotypic kappa ( Figure 3A,B) , with a strong expression of CD20 and expression CD10, and negative for CD5 and CD38 expression ( Figure 3C ,D). Cytology and immunophenotyping were in favor of a diffuse large B-cell lymphoma (DLBCL), but were insufficient to make a precise diagnostic. Moreover, virological tests were performed on a whole blood sample and revealed the presence of EpsteinBarr virus (EBV) DNA with a viral load of 4.24 log 10 copies/ mL. A bone marrow biopsy was performed. It revealed typical Reed-Sternberg cells ( Figure 4A ) suggesting the diagnosis Figure 4D) . Surprisingly, the population of CD10+ lymphocytes detected with the bone marrow immunophenotyping could not be detected in the bone marrow biopsy. 5 The final diagnosis was a Richter syndrome transforming a marginal zone lymphoma into a DLBCL associated with a stage IV lymphocyte-depleted classic Hodgkin lymphoma revealed by a hemophagocytic syndrome.
Before the results of the biopsy, the patient received one cycle of COP chemotherapy (Cyclophosphamide, Vincristine and Prednisone) aiming to treat his DLBCL. When the diagnosis of HL was firmly established, he was treated by ABVD chemotherapy (Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine) associated with VP16 (Etoposide) to treat the hemophagocytic syndrome. After two cycles of ABVD chemotherapy, a slight lymphocytosis remained. A second immunophenotyping revealed a persistent CD20+ CD10+ lymphocyte population. The patient was then treated by three cycles of R-CHOEP chemotherapy (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Etoposide, and Prednisone). The initial response to this therapy was satisfactory, with improvement of the hemophagocytic syndrome and decrease in the ferritin levels from 29 211 to 9437 pmol/L. After the third R-CHOEP cycle, the patient was admitted to the hospital because of a sepsis triggered by a urinary infection. His general state quickly worsened, and a second bone marrow aspirate revealed a relapse of the hemophagocytic syndrome ( Figure  2C ) and a persistence of the Hodgkin lymphoma ( Figure  2D ). Despite antibiotic treatment and chemotherapy with high doses of Etoposide, Rituximab, and Cisplatin, there was no amelioration and a multiple organ failure led to the patient's decease.
| DISCUSSION
The occurrence of concomitant classic Hodgkin lymphoma and a variety of B-cell non-Hodgkin lymphoma (NHL) in the same tissue defines the diagnostic criteria for composite lymphomas. Composite lymphomas have been described in the literature [6] [7] [8] [9] [10] [11] with association of: Hodgkin lymphoma with gastric mucosa-associated lymphoid tissue (MALT) lymphoma, 6 splenic marginal zone lymphoma, 7,8 follicular lymphoma, 9 chronic lymphocytic leukaemia, 10 or large Bcell lymphoma.
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To the best of our knowledge, there is no case report of a Hodgkin lymphoma with medullary involvement and a DLBCL.
Numerous studies aimed to identify a common B-cell precursor in patients with both Hodgkin lymphoma and NHL. presenting sequentially a splenic marginal zone lymphoma, a Hodgkin lymphoma, and a DLBCL (thought to be the evolution of the MZL) was reported (Sara Alvaro et al case report 2016 13 ). The analysis of clonally rearranged IGH genes revealed the three histological types of lymphoma had the exact same clonal IGH rearrangement.
Composite lymphoma diagnosis represents a challenge due to the heterogeneity of clinical, biological, and histological aspects of the disease. It has to be suspected when a discrepancy occurs between the different histological tests carried out. In the case reported here, the results of the bone marrow aspirate and the bone marrow biopsy were discordant. Firstly, each exploration test limits have to be considered. For instance, CD10+ lymphocytes were not detected by immunohistochemistry tests on the biopsy, whereas this lymphocyte population was found on the bone marrow immunophenotyping. It has already been described that the antibodies used for these two tests target different epitopes, 14 and that the immunohistochemistry is less sensible than the immunophenotyping because the epitopes targeted in this technique are more likely to disappear when the patient develops a DLBCL. As a second example, it is exceptional to see a Hodgkin cell or a Reed-Sternberg cell on a bone marrow smear. This technique is known to be less sensible than the bone marrow biopsy to detect these types of cells. 5 Moreover, when a DLBCL is suspected, it has already been described that Sternberg-like cells may be observed on the bone marrow smear. [2] [3] [4] Secondly, it is important to do repeated tests in various sites in order to increase the sensitivity. A lymph node aspirate or biopsy could have given further information, but was impossible due to the location of the patient's lymphadenopathy and his frail condition. In summary, in the case reported here, the correct diagnosis was possible by correlating clinical, cytological, and pathological features of the patient's history allowing to identify this case as a Richter syndrome resulting from the transformation of a marginal zone lymphoma into a DLBCL associated with a Hodgkin lymphoma. As a result, the treatment was adapted to target both components of this composite lymphoma.
